Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Etiology, Diagnosis, Pathophysiology, and Treatment (R01) | Apply Online

Opportunity Summary:

The NIH funding opportunity PAR 12-032, titled "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Etiology, Diagnosis, Pathophysiology, and Treatment (R01)," is a discretionary grant program that supports investigator-initiated R01 research projects focused on ME/CFS (also referred to as CFS or myalgic encephalomyelitis). It is issued by the Office of Research on Women's Health (ORWH) and co-sponsored by multiple NIH Institutes and Centers, signaling a broad, cross-cutting interest in understanding and improving outcomes for a complex illness that affects multiple organ systems and diverse populations.

The central goal of the announcement is to advance scientific understanding of ME/CFS by encouraging studies that address four major areas: causes (etiology), better ways to identify and classify the illness (diagnosis), the biological mechanisms that drive symptoms and disability (pathophysiology), and approaches to prevent, manage, or treat the condition (treatment). The FOA places special emphasis on research that looks across the lifespan and includes diverse groups, reflecting the need to understand how ME/CFS presents and progresses in different ages, sexes, and populations and why experiences and outcomes may vary.

A major theme of the FOA is closing key knowledge gaps. NIH is explicitly interested in studies that clarify environmental and biological risk factors that may contribute to the onset and persistence of ME/CFS, as well as the factors that explain heterogeneity among patients, meaning why the condition can look different from one person to another. This can include work aimed at identifying subtypes, endophenotypes, or clinically meaningful groupings based on symptoms, triggers, comorbidities, physiology, or molecular signatures. The announcement also highlights the need to identify common mechanisms that influence the multiple body systems affected in ME/CFS, which encourages integrative research that connects findings across immune, neurologic, autonomic, endocrine, metabolic, infectious, or other relevant pathways.

NIH also signals that it wants interdisciplinary research that leads to practical, evidence-based improvements in diagnosis, treatment, and quality of life. This includes building scientific teams capable of combining clinical expertise with modern laboratory, computational, and translational approaches. Examples of the kinds of work the FOA is designed to stimulate include developing and validating biomarkers that could improve diagnostic accuracy or help stratify patients for trials, testing innovative treatment modalities, and studying modifiable risk or protective processes that could be targeted through prevention strategies or therapeutic interventions. In other words, the intent is not only to describe the illness but to generate findings that can translate into real-world clinical tools and better care.

From an administrative standpoint, this is an NIH R01 grant mechanism, categorized under discretionary funding, and it does not require cost sharing or matching. It was posted November 18, 2011, with later administrative updates reflected in the record (creation date December 9, 2014). The opportunity is now archived; the original closing date listed is October 24, 2014, with a final closing date of February 24, 2015, and an archive date of March 24, 2015. The record also lists several CFDA program numbers associated with participating NIH areas (including programs related to oral diseases, alcohol research, neurosciences and neurological disorders, allergy and infectious diseases, and microbiology and infectious diseases), underscoring the broad biomedical scope that NIH considers relevant to ME/CFS research.

Eligibility is expansive and includes many types of domestic U.S. applicants such as state, county, city, and special district governments; public and private institutions of higher education; independent school districts; public housing authorities; nonprofits with or without 501(c)(3) status; and for-profit organizations other than small businesses, as well as small businesses. The FOA also allows a wide range of mission-focused institutions and organizations to apply, including historically Black colleges and universities, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian serving institutions, and faith-based or community-based organizations, among others. Importantly, foreign institutions are eligible to apply, non-U.S. components of U.S. organizations are eligible, and foreign components (as defined by NIH policy) are allowed, which opens the door to international collaboration where it strengthens the science.

For applicants or readers needing the full official announcement, the additional information link provided is the NIH Grants Guide page for PAR 12-032. Technical issues accessing the announcement are directed to the NIH Office of Extramural Research (OER) Webmaster via the listed email address.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Environment Food and Nutrition Health

Next opportunity: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Etiology, Diagnosis, Pathophysiology, and Treatment (R21)

Previous opportunity: Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 12 032

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 12 032) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 12 032", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.